Case reports in ophthalmological medicine · 2026
Sulcus Placement of PreserFlo Microshunt in Iridocorneal Endothelial Syndrome: A Case Report.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rana Khizar, Shi Cindy, Stavrinakis Stephanie, Ng Soo Khai
Аннотация
BACKGROUND: Secondary angle-closure glaucoma associated with iridocorneal endothelial (ICE) syndrome can be challenging to manage. This report presents a novel case of sulcus placement of a PreserFlo Microshunt in a patient with ICE syndrome following the failure of previous trabeculectomy and medical therapy.
CASE PRESENTATION: A 61-year-old patient with secondary angle-closure glaucoma due to ICE syndrome had uncontrolled intraocular pressures despite maximal medical therapy. They had a previous trabeculectomy, which failed following cataract surgery. Because of extensive peripheral anterior synechiae and risk of corneal decompensation, a PreserFlo Microshunt was placed in the sulcus. At the 18-month postoperative follow-up, intraocular pressure was well controlled without topical therapy.
CONCLUSION: This is the first reported case of a PreserFlo Microshunt implanted in the sulcus in ICE syndrome. Sulcus placement provides a viable alternative in pseudophakic patients with extensive peripheral anterior synechiae, helping to mitigate the risk of corneal decompensation while effectively controlling intraocular pressure.
CASE PRESENTATION: A 61-year-old patient with secondary angle-closure glaucoma due to ICE syndrome had uncontrolled intraocular pressures despite maximal medical therapy. They had a previous trabeculectomy, which failed following cataract surgery. Because of extensive peripheral anterior synechiae and risk of corneal decompensation, a PreserFlo Microshunt was placed in the sulcus. At the 18-month postoperative follow-up, intraocular pressure was well controlled without topical therapy.
CONCLUSION: This is the first reported case of a PreserFlo Microshunt implanted in the sulcus in ICE syndrome. Sulcus placement provides a viable alternative in pseudophakic patients with extensive peripheral anterior synechiae, helping to mitigate the risk of corneal decompensation while effectively controlling intraocular pressure.